This announcement is a separate document:
科源制药:中信建投证券股份有限公司关于山东科源制药股份有限公司2023年度跟踪报告
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.'s 2023 follow-up report on Shandong Keyuan Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.